The global clinical trial payments solutions market is expected to rise from USD 2.30 billion in 2026 and is projected to reach USD 7.40 billion by 2040, growing at a CAGR of 8.7% over the forecast period 2026 to 2040, driven by faster site payments, participant reimbursement automation, and cross-border payout complexity. Based on payment method, direct deposits / ACH capture 27.0% market share in 2026, whereas other local payout methods register a 15.4% CAGR through 2040, driven by localized c...

The global AI in neurology market is expected to rise from USD 0.92 billion in 2026 and is projected to reach USD 12.81 billion by 2040, growing at a CAGR of 20.7% over the forecast period 2026 to 2040, driven by faster neuroimaging, clinical decision support, and precision neurology adoption. Based on offering, Software and Platforms capture 62.0% market share in 2026, whereas AI-Enabled Devices and Hardware registers a 22.4% CAGR through 2040, supported by expanding neurotechnology and closed-...

The global teleradiology services market, valued at USD 9.2 billion in 2025, is projected to reach USD 10.1 billion in 2026 and USD 23.3 billion by 2035, representing a CAGR of 9.7% during the forecast period 2026 to 2035. In terms of imaging modality, CT scan accounted for 35% of market revenues in 2026.With respect to end user, hospitals (51%) dominate the current market.

The global healthcare LLMOps market is expected to rise from USD 1.25 billion in 2026 to reach USD 22.40 billion by 2040, growing at a CAGR of 22.9% over the forecast period 2026 to 2040, driven by governed clinical AI workflows and agentic automation. Based on Deployment Mode, Public cloud deployment captures 49.0% market share in 2026, whereas Hybrid cloud deployment registers a 25.0% CAGR through 2040, as regulated workloads balance hyperscale AI with local controls. Based on Application / Us...

The global clinical trial simulation market is expected to rise from USD 4.2 billion in 2026 to reach USD 11.8 billion by 2040, growing at a CAGR of 7.7% over the forecast period 2026 to 2040, driven by regulatory acceptance and AI-generated virtual patients. Based on application, dose and dosing-regimen optimization captures 24.0% market share in 2026, whereas synthetic or external control generation registers an 11.9% CAGR through 2040, supported by smaller trial cohorts. Based on end user, ph...

The global healthcare RAG market is expected to rise from USD 0.9 billion in 2026 and is projected to reach USD 36.0 billion by 2040, growing at a CAGR of 30.1% over the forecast period 2026 to 2040, driven by clinical trust, traceable answers, and EHR-grounded AI workflows. Based on deployment model, cloud-based deployment captures 61.0% market share in 2026, whereas hybrid deployment registers a 35.1% CAGR through 2040, driven by protected health data controls. Based on application, clinical d...

The global prescription DTx market is expected to rise from USD 5.8 billion in 2026 to reach USD 75.0 billion by 2040, growing at a CAGR of 20.1% over the forecast period 2026 to 2040, driven by reimbursement pathways, FDA-cleared software therapies, and chronic-care digitization. Based on geography, North America captures 44.0% market share in 2026, whereas Asia-Pacific registers a 23.0% CAGR through 2040, driven by localized reimbursement and regulatory pathways. Based on application, diabetes...

The global stroke AI market is expected to rise from USD 0.44 billion in 2026 to reach USD 8.05 billion by 2040, growing at a CAGR of 23.1% over the forecast period 2026 to 2040, driven by time-critical stroke detection, care-team activation, and automated treatment-routing workflows. Based on offering, AI imaging and triage software captures 47.0% market share in 2026, whereas analytics and performance-management services register a 28.4% CAGR through 2040, driven by outcomes tracking. Based on...

The global AI in medical scribing market reached USD 1.82 billion in 2026 and is projected to reach USD 22.3 billion by 2040, growing at a CAGR of 19.6% over the forecast period 2026 to 2040, driven by clinician burnout reduction and EHR-native ambient documentation. Ambient clinical documentation is moving from transcription replacement to EHR-integrated clinical workflow automation. Hospitals first bought AI medical scribe software to reduce note burden and after-hours charting.

The global triage system market is estimated at USD 9.8 billion in 2026 and is projected to reach USD 42.2 billion by 2040, growing at a CAGR of 11.0% over the forecast period 2026 to 2040, driven by AI-enabled emergency department prioritization, virtual front-door triage, and EHR-integrated decision-support tools. Regulatory classification and workflow validation slow adoption because triage tools influence patient routing and clinical prioritization. Infermedica’s September 2025 MDR Class I...

The global AI in medical coding market is expected to rise from USD 3.4 billion in 2026 and reach USD 16.2 billion by 2040, growing at a CAGR of 11.8% over the forecast period 2026 to 2040, driven by revenue cycle automation and coder productivity pressure. Based on Component, Software platforms is both the dominant and fastest-growing category, holding 72.0% share in 2026 and expanding at 12.4% CAGR through 2040, driven by scalable autonomous coding engines. Compliance exposure restrains autono...

The global clinical workflow solutions market is expected to rise from USD 14.8 billion in 2026 to reach USD 71.7 billion by 2040, growing at a CAGR of 11.9% over the forecast period 2026 to 2040, driven by EHR-integrated automation, cloud deployment, and AI-enabled documentation. The clinical workflow solutions market is shifting from fragmented messaging and data tools into AI-enabled operating layers. Hospitals now need platforms that connect EHR data, alerts, documentation, orders, analytics...

The global connected medical device cybersecurity market reached USD 9.7 billion in 2026 and is projected to reach USD 50.0 billion by 2040, growing at a CAGR of 12.43% over the forecast period 2026 to 2040, driven by rising IoMT exposure, FDA cybersecurity requirements, and hospital network risk. Based on geography, North America captures 42.0% market share in 2026, whereas Asia-Pacific registers a 14.9% CAGR through 2040, driven by hospital digitization and regulatory catch-up. Based on applic...

The quantum computing in drug discovery market, valued at USD 315 million in 2025, is projected to reach USD 361 million in 2026 and USD 1,692 million by 2035, representing a CAGR of 18.7% during the forecast period 2026 to 2035. In terms of geographical regions, North America captures more than 40% of the market value in the year 2026, due to its strong public and private investments, supportive regulations, and significant funding. In February 2026, XtalPi entered into a collaboration with VIS...

The global cardiac RPM market reached USD 5.2 billion in 2026 and is projected to reach USD 22.8 billion by 2040, growing at a CAGR of 11.1% over the forecast period 2026 to 2040, driven by rising arrhythmia burden, heart failure readmission pressure, and connected ambulatory monitoring adoption. Cardiology monitoring is moving from episodic Holter testing toward continuous, connected, and home-linked care pathways. The cardiac RPM market now combines ECG patches, mobile cardiac telemetry, CIED...

The global AI-Powered claim denial management market is expected to rise from USD 1.35 billion in 2026 and is projected to reach USD 15.0 billion by 2040, growing at a CAGR of 18.8% over the forecast period 2026 to 2040, driven by rising claim denials and payer-policy complexity. Based on geography, North America captures 47.0% market share in 2026, whereas Asia-Pacific registers a 22.6% CAGR through 2040, driven by public claims digitization.

The cloud computing market, valued at USD 818 billion in 2025, is projected to grow to USD 950 billion in 2026 and USD 5,608 billion by 2040, representing a CAGR of 13.52% during the forecast period. The high demand for flexible and cost-effective IT solutions has led to a shift from conventional on-premises systems to cloud-based services, enhancing efficiency and minimizing operational costs. This shift reduces the need for extensive physical hardware and maintenance, allowing businesses t...

The global pharma cloud services market, valued at USD 10.8 billion in 2025, is projected to reach USD 13.0 billion in 2026 and USD 42.9 billion by 2035, representing a CAGR of 14.2% during the forecast period 2026 to 2035. In terms of area of application, drug discovery holds the highest share (nearly 50%) of the market. In terms of end user, pharmaceutical and life science companies hold the highest share (65%) of the current market. In terms of geographical regions, North America holds the hi...

The global AI in drug manufacturing market is estimated to grow from USD 0.9 billion in 2025 to reach USD 1.2 billion in 2026 and USD 34.8 billion by 2040, representing a CAGR of 27.2% during the forecast period 2026 to 2040. In June 2025, Aizon entered into a partnership with Sequence aimed at delivering comprehensive, AI-powered solutions for the pharmaceutical industry. Based on the type of AI solution, the global market includes standard / off-the-shelf AI solutions and personalized AI solut...

The global federated learning in healthcare market is expected to rise from USD 40.0 million in 2026 to reach USD 282.6 million by 2040, growing at a CAGR of 15.0% over the forecast period 2026 to 2040, driven by privacy-preserving collaboration across fragmented clinical datasets. The federated learning healthcare market has moved from research-led hospital pilots toward commercial platforms connecting clinical, molecular, and imaging data. Drug discovery now leads application demand with 34.5%...